How to take useful drugs without hurting yourself
Lundberg, G.D.
Medgenmed Medscape General Medicine 7(1): 53
2005
ISSN/ISBN: 1531-0132 PMID: 16369358 Document Number: 590151
Document emailed within 1 workday
Related Documents
Holoweiko, M. 1984: Doctor entrepreneurs: are they hurting the profession? Medical Economics 61(17): 116-124; 129, 133Zigmond, J. 2006: Gulf Coast still hurting: study Modern Healthcare 36(34): 14
Barbour, A.; Ham, O.A. 1990: Are creeping salary inequities hurting your practice? Dental Management 30(1): 36-38; 40
Crane, M. 1986: How badly are cost controls hurting patients? Medical Economics 63(8): 60-64
Kirchner, M. 1983: Special report: how the health-cost backlash is hurting you Medical Economics 60(11): 47-8 51-2
Goozner, M. 2013: Op out at your own peril. States may be hurting their own citizens by letting feds run exchanges Modern Healthcare 43(7): 25
Paxton, H.T. 1986: How badly is cost-containment hurting patient care? Panel discussion Medical Economics 63(19): 48-64
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Marek, J. 1985: On the non-specific antiinflammatory effects of other-than-antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs International Journal of Tissue Reactions 7(6): 475-504
Yanaginuma, T. 1984: Clinical pharmacology for midwives. 3. Pregnancy and drugs. 3. Drugs with their risk superseding the benefits Josanpu Zasshi 38(6): 526-530
Wong, I.C. 1997: New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years Bmj 314(7080): 603-604
Degkwitz, R. 1980: Psychotropic drugs. Sense and nonsense in the prescription of sedating, psycholeptic and hypnotic drugs Zfa. Zeitschrift für Allgemeinmedizin 56(2): 77-83
Allen, L.V. 1995: Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs? PDA Journal of Pharmaceutical Science and Technology 49(6): 306-308
Villette, B.; Rybojad, M.; Puissant, A. 1989: Dermatologic manifestation of undesirable effects of drugs (excluding cytostatic drugs) Annales de Medecine Interne 140(7): 609-613
Nargeolet, H. 1972: Misuse of drugs and excess of self-administered drugs. Administrative and legislative problems Therapie 27(2): 289-295
Jacob, J.; Barthelemy, C. 1972: Misuse of drugs and excess of self-administered drugs. Problems posed for the pharmacologist Therapie 27(2): 189-217
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Biour, M.; Poupon, R.; Grange, J.D.; Chazouillères, O.; Lévy, V.G.; Jaillon, P. 1997: Hepatotoxicity of drugs. 10th update of the bibliographic database of hepatic involvements and responsible drugs Gastroenterologie Clinique et Biologique 21(10): 660-696
Fernández de Córdova-Rodríguez1, L.R.é; Guzmán-Guillén, K.A.; Fernández de Córdova-Aguirre, J.C. 2015: DRESS syndrome or reaction to drugs with eosinophilia and systemic symptoms associated to anti-tuberculosis drugs Revista Alergia Mexico 62(2): 149-156